CLINICAL_TRIALS
trial_result
· 2022-06-01
Clinical Trial Update: Esteem New Subject Enrollment Post Approval Study [NA]
Summary
A post-approval study completed enrollment for patients with sensorineural hearing loss; results were posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Envoy Medical Corporation | Conditions: Sensorineural Hearing Loss | NA | Status: COMPLETED | Results posted: 2022-06-01